Reconstitution of CXCR3+CCR6+ Th17.1‐Like T Cells in Response to Ofatumumab Therapy in Patients With Multiple Sclerosis

奥图穆马 医学 免疫学 纳塔利祖玛 T细胞 外周血单个核细胞 流式细胞术 CXCR3型 免疫系统 离体 FOXP3型 多发性硬化 内科学 CD20 抗体 体内 体外 趋化因子 生物 生物技术 趋化因子受体 生物化学
作者
Shu Yang,Tianxiang Zhang,Jia Liu,Zhirui Liu,Lijie Zhu,Yanyan Li,Bin Feng,Moli Fan,Fu‐Dong Shi,Chao Zhang
出处
期刊:Annals of clinical and translational neurology [Wiley]
卷期号:12 (5): 1043-1053 被引量:5
标识
DOI:10.1002/acn3.70042
摘要

ABSTRACT Background and Objectives Ofatumumab, a fully human anti‐CD20 monoclonal antibody, is effective in reducing relapses and disability progression in patients with multiple sclerosis. This study aimed to examine immune profile changes associated with ofatumumab in a prospective cohort of Chinese patients with relapsing–remitting multiple sclerosis (RRMS). Methods Seventeen RRMS patients were enrolled in this uncontrolled, prospective, observational cohort study (OMNISCIENCE study) and received regular subcutaneous ofatumumab treatments. Immune cell subsets were analyzed by single‐cell mass cytometry at baseline and 6 months post‐treatment. Peripheral blood monoclonal cells (PBMCs) from a separate cohort of treatment‐naive RRMS patients were used for cytokine analysis through ex vivo flow cytometry. Results Following ofatumumab treatment, B cells in peripheral blood remained depleted, with surviving cells predominantly consisting of antibody‐secreting cells and transitional B cells. Increased proportions of NK cells and myeloid cells, particularly HLA‐DR hi intermediate monocytes, were observed, and FOXP3 and CTLA‐4 expression on CD4 + T cells was upregulated. Notably, prior to the subsequent dose of ofatumumab, Th17.1‐like CXCR3 + CCR6 + memory CD4 + and CD8 + T cell clusters increased significantly, with a transient CD20 expression rebound. In vitro experiments further confirmed that ofatumumab reduced these Th17.1 cell subsets and related pro‐inflammatory cytokines. Discussion These findings suggest that ofatumumab impacts interactions among pathogenic B cells, T cells, and myeloid cells, with Th17.1 cells emerging as a potential direct target within T cells. Persistent and regular infusions of ofatumumab appear necessary to sustain clinical efficacy. Trial Registration: ClinicalTrials.gov identifier: NCT05414487
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
123发布了新的文献求助10
1秒前
1秒前
1秒前
3秒前
3秒前
可乐发布了新的文献求助10
3秒前
David完成签到,获得积分10
4秒前
4秒前
4秒前
爱笑绿柳完成签到,获得积分10
4秒前
cbs完成签到 ,获得积分10
5秒前
5秒前
能干的绯发布了新的文献求助10
5秒前
书包王发布了新的文献求助10
6秒前
杨凡华完成签到,获得积分10
6秒前
7秒前
科研通AI2S的应助被Shu舒采纳,获得10
7秒前
7秒前
领导范儿的应助被南海神尼采纳,获得10
7秒前
8秒前
共享精神的应助被vv采纳,获得10
8秒前
moss完成签到 ,获得积分10
8秒前
feihua1完成签到 ,获得积分10
8秒前
搜集达人的应助被爱笑绿柳采纳,获得10
8秒前
FashionBoy的应助被寒冷鸭子采纳,获得10
8秒前
欣喜若灵发布了新的文献求助10
9秒前
哈哈发布了新的文献求助10
9秒前
9秒前
9秒前
10秒前
10秒前
科研通AI65的应助被qwer采纳,获得10
10秒前
11秒前
11秒前
老实幻姬完成签到,获得积分10
11秒前
虚幻百川完成签到,获得积分0
12秒前
虚拟的水壶完成签到,获得积分10
12秒前
12秒前
momo123完成签到,获得积分10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482